New Cancer Vaccine Boosts Hope for Skin Cancer Patients
A new personalized vaccine helps stop skin cancer from returning, offering a big step forward for patients.
Imagine a world where your own body fights cancer better. Merck and Moderna brought us closer to that world. Their new vaccine helps people with skin cancer. This vaccine is special because it works with another drug called Keytruda.
Doctors gave the vaccine and Keytruda to patients. These patients had a serious type of skin cancer. They were at high risk of their cancer coming back. The results show the treatment slowed the return of cancer. This is great news for many patients.
This personalized vaccine uses mRNA technology. Moderna used this same tech for its COVID-19 vaccine. Now, it helps fight cancer. This success in a big study means the companies can ask for quick approval. This could bring the treatment to patients sooner.
Source: FierceBiotech
More from Biotech
